Pharmafile Logo

Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

November 26, 2024 |  

A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition for the life science industry.

David W. Miller

Genesis Research Group empowers life science companies to ‘innovate differently’. What do you mean by this and how did this approach come about?

The life science industry is a complex and dynamic marketplace where life sciences companies are constantly having to adapt their research needs to changing circumstances. Since its inception in 2009, Genesis Research Group has made a point of listening to our clients, and the message we’ve taken on board comes down to three essential components: quality, efficiency, and agility.

At Genesis Research Group, we have fundamentally transformed the way life sciences companies engage with research partners. We are helping them to innovate differently by enabling them to infuse efficiencies throughout product development. Our business model is built upon the notion that you cannot rely on one technology or team to provide the solutions that are needed; instead, you need a partner that fuses advanced technology with decades of hands-on experience. With this in mind…

Read the full article here.

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

World EPA Congress 2024: ‘Shining the light on vaccine market access’ by Genesis Research Group

A presentation with Katrin Nather, PhD, Associate Director, and Tijana Ignjatovic, Executive Director, Genesis Research Group. Contact solutions@genesisrg.com or visit www.genesisrg.com. With more and more innovative vaccines and immunization strategies...

Fit-for-purpose matchmaking webinar: a data selection and RWE approach for both regulatory and HTA audiences

This webinar reviews considerations for the design and data selection for RWE studies, including external control arm studies, to meet regulatory and HTA needs. Regulators and agencies responsible for market...

Genesis Research Group RWD / HTA / regulatory / ECA webinar on 15 Feb: reserve your place!

On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar...

Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!

Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to...

Leading pharmaceutical executive Jennifer Fillman joins evidence-based solution provider Genesis Research as Chief Financial Officer

International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to joining...